Biosite Agrees To Inverness Merger Talks While Beckman Waits At The Altar
This article was originally published in The Gray Sheet
Executive Summary
Heart test maker Biosite has agreed to merger talks with Inverness Medical Innovations despite its previous agreement to be acquired by Beckman Coulter for $1.55 billion